Exelixis Inc

2026-10-27 19:36; UTC

Exelixis Inc is trading slightly higher, maintaining its position above the 20-day moving average and near the upper end of its one-month trading range.

2026-10-26 20:07; UTC

Exelixis Inc shares are advancing amid a broader market rally, supported by positive economic indicators including the Dallas Fed Manufacturing Index exceeding expectations.

2026-10-23 20:07; UTC

Exelixis Inc shares are declining amid a broadly lower market, reflecting rising oil prices, inflation concerns, and geopolitical tensions affecting investor sentiment.

2026-10-21 19:26; UTC

Exelixis Inc shares are trading slightly higher, supported by positive momentum in the broader biotechnology sector, despite an earlier pullback from a session high.

2026-10-20 20:08; UTC

Exelixis Inc shares advanced, closing significantly higher and reaching a notable peak, remaining well above its 20-day moving average.

2026-10-19 20:07; UTC

Citizens maintains Market Outperform rating on Exelixis and raises price target to $65, contributing to a modest gain in the stock.

2026-10-16 19:16; UTC

Exelixis Inc shares fell significantly from an early high, remaining above the 20-day moving average despite today's notable decline.

2026-10-15 20:07; UTC

Exelixis Inc shares advanced, continuing a trend of gains since Wednesday's close, remaining significantly above its 20-day moving average despite an earlier pullback.

2026-10-14 19:16; UTC

Exelixis Inc shares are advancing, reaching a notable peak in early afternoon trading and positioned well above its 20-day moving average.

2026-10-13 20:08; UTC

Exelixis Inc shares are modestly lower, retracing from an early gain, amid a broader market decline.

2026-10-12 21:02; UTC

Exelixis Inc shares declined in after-market trading, continuing lower since Monday's close and diverging from a recent trend of higher daily closes.

2026-10-09 20:06; UTC

RBC Capital raised its price target on Exelixis Inc to $51 while maintaining a Sector Perform rating, coinciding with the stock's positive performance.

2026-10-08 20:07; UTC

Exelixis Inc's shares advanced, supported by broader market strength, maintaining an upward trajectory despite an earlier pullback from a session high.

2026-10-07 19:45; UTC

Exelixis Inc shares are trading higher as Truist Securities raises the price target to $54.00 from $52.00 while maintaining a Hold rating.

2026-10-06 21:01; UTC

Exelixis Inc is trading modestly lower in after-market hours, positioned around the midpoint of its one-month trading range.

2026-10-05 21:10; UTC

Exelixis Inc. is advancing in after-market trading, closing at its highest point of the day after three consecutive sessions of gains.

2026-10-02 20:00; UTC

Exelixis Inc shares are advancing, reaching a peak cumulative return and remaining well above their 20-day moving average during Friday's market session.

2026-10-01 20:07; UTC

Exelixis Inc's shares fell modestly, reflecting routine performance amid broader market conditions, and are currently near the low end of their daily range.

2026-09-30 23:20; UTC

Exelixis Inc shares are higher in after-market trading, continuing a five-day gain, supported by strong Q2 GDP growth despite mixed inflation and consumer spending signals.

2026-09-29 20:31; UTC

Exelixis Inc saw a significant decline in after-market trading, continuing a downward trend since Tuesday's close following earlier gains.

2026-09-28 19:16; UTC

Exelixis Inc is trading modestly higher, currently 2.25% above its 20-day moving average, reflecting routine activity for this time of day.

2026-09-25 23:20; UTC

Exelixis Inc is lower in after-market trading, retracing from an early gain and reflecting a decline since Friday's close.

2026-09-24 20:01; UTC

Exelixis Inc is advancing, peaking in mid-afternoon while remaining above its 20-day moving average and near the upper end of its one-month range.

2026-09-23 20:07; UTC

Exelixis Inc shares fell significantly on Wednesday, having briefly spiked earlier in the session, reflecting a lack of momentum in either direction.

2026-09-22 20:06; UTC

Exelixis Inc is gaining today, building on Monday's momentum, with the stock remaining above its 20-day moving average and near its one-month range's upper end.

2026-09-21 23:25; UTC

Exelixis Inc is trading modestly lower in after-market hours, continuing a decline seen over the past three sessions after reaching a session high.

2026-09-18 20:06; UTC

Exelixis Inc's shares fell sharply after reaching a notable peak earlier in the session, while remaining above the 20-day moving average.

2026-09-16 20:07; UTC

Exelixis Inc shares fell sharply, retracing from an early peak in cumulative return amid unusually high market volume on Wednesday.

2026-09-15 20:07; UTC

Exelixis Inc. shares are higher as the company expands CABOMETYX in renal cell carcinoma and neuroendocrine tumors, reflecting investor confidence amid broader market concerns.

2026-09-14 20:07; UTC

Exelixis shares are rising after BMO indicated the FDA's PDUFA date extension for Zanzalintinib is procedural, maintaining a $55 price target.